arrow
U

Uptal D. Patel

Biogen
H指数:56
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies

Felzartamab抗CD38治疗对肾移植活检中抗体介导排斥反应分子表型的影响

2025-10-010
PRE
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy
2024-09-013
OAAI
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
2024-07-1114
PRE
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine

慢性肾病的无偏见的以肾脏为中心的分子分类是迈向精确医学的一步

2024-06-012
OAAI
Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study
2020-01-0122
OAAI